Hi, what are you looking for?
Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol™ in dogs with naturally occurring cancer. Attaxol™ was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company.
Source: DogMagazine.net – the K9 Magazine blog
New Canine Cancer Drug Could Save Lives
Related content:
A survey of more than 4,000 members of the public by PFMA, the Pet Food Manufacturers’ Association, reveals 90% of people think that separation...
The British Veterinary Association (BVA) is pleased to announce Mr Derek Williams as the new non-executive Chairman of the Board and Mr Ted Chandler...
Over the past 15 years there has been a rocket-like surge in the depth and availabilty of pet insurance policies in the UK. As...
A few months ago we told our readers about a campaign that aimed to reform regulation of the veterinary profession, formerly know as Justice...
